Estrogen Receptor and Progesterone Receptor As Predictive Biomarkers of Response to Endocrine Therapy: A Prospectively Powered Pathology Study in the Tamoxifen and Exemestane Adjuvant Multinational Trial

PURPOSE: The Tamoxifen and Exemestane Adjuvant Multinational (TEAM) trial included a prospectively planned pathology substudy testing the predictive value of progesterone receptor (PgR) expression for outcome of estrogen receptor–positive (ER-positive) early breast cancer treated with exemestane ver...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Bartlett, John M.S., Brookes, Cassandra L., Robson, Tammy, van de Velde, Cornelis J.H., Billingham, Lucinda J., Campbell, Fiona M., Grant, Margaret, Hasenburg, Annette, Hille, Elysée T.M., Kay, Charlene, Kieback, Dirk G., Putter, Hein, Markopoulos, Christos, Kranenbarg, Elma Meershoek-Klein, Mallon, Elizabeth A., Dirix, Luc, Seynaeve, Caroline, Rea, Daniel
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2011
Assuntos:
Original Reports
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3082973/
https://ncbi.nlm.nih.gov/pubmed/21422407
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.30.3677
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares